{
"id":"mk19_b_cv_t47",
"number":47,
"bookId":"cv",
"title":{
"__html":"Anticoagulation Regimens During Pregnancy"
},
"jsonContent":{
"type":"tag",
"tagName":"table",
"attrs":{
"className":"table"
},
"children":[
{
"type":"tag",
"tagName":"caption",
"attrs":{
},
"children":[
{
"type":"p",
"hlId":"0b1f70",
"children":[
{
"type":"tag",
"tagName":"b",
"attrs":{
"className":"table-number"
},
"children":[
{
"type":"tag",
"tagName":"span",
"attrs":{
},
"children":[
"Table 47. "
]
},
{
"type":"new-window-link",
"targetType":"table",
"targetId":"mk19_b_cv_t47"
}
]
},
"Anticoagulation Regimens During Pregnancy"
]
}
]
},
{
"type":"tag",
"tagName":"thead",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"5b07cd",
"class":"col hd l",
"children":[
"Weeks of Gestation"
]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"390eeb",
"class":"col hd l",
"children":[
"Recommended Regimen"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"2"
},
"children":[
" ",
{
"type":"p",
"hlId":"934476",
"class":"col hd l",
"children":[
"Venous Thromboembolism"
]
},
" "
]
}
]
}
]
},
{
"type":"tag",
"tagName":"tbody",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"dac39a",
"class":"cell txt l",
"children":[
"Weeks 6 to term"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d28627",
"class":"cell txt l",
"children":[
"Weight-based LMWH"
]
},
" ",
{
"type":"p",
"hlId":"22991e",
"class":"cell txt l",
"children":[
"UFH (IV or SQ; aPTT 2 × control)"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"2"
},
"children":[
" ",
{
"type":"p",
"hlId":"3d0b99",
"class":"col hd l",
"children":[
"Nonvalvular Atrial Fibrillation"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_2-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"786fe4",
"class":"cell txt l",
"children":[
"Weeks 6-12"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"1d1c45",
"class":"cell txt l",
"children":[
"Warfarin (if dose to attain therapeutic INR ≤5 mg)"
]
},
" ",
{
"type":"p",
"hlId":"22991e",
"class":"cell txt l",
"children":[
"UFH (IV or SQ; aPTT 2 × control)"
]
},
" ",
{
"type":"p",
"hlId":"d28627",
"class":"cell txt l",
"children":[
"Weight-based LMWH"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_2-2 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"5ad4d8",
"class":"cell txt l",
"children":[
"Weeks 13-37"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"2ea3e7",
"class":"cell txt l",
"children":[
"UFH (SQ; aPTT 2 × control)"
]
},
" ",
{
"type":"p",
"hlId":"d28627",
"class":"cell txt l",
"children":[
"Weight-based LMWH"
]
},
" ",
{
"type":"p",
"hlId":"46f963",
"class":"cell txt l",
"children":[
"Warfarin (therapeutic INR)"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_2-3 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"121d94",
"class":"cell txt l",
"children":[
"Weeks 37 to term"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"910e13",
"class":"cell txt l",
"children":[
"UFH (IV; aPTT 2 × control)"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"2"
},
"children":[
" ",
{
"type":"p",
"hlId":"02d510",
"class":"col hd l",
"children":[
"Mechanical Valve Prosthesis"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_3-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"786fe4",
"class":"cell txt l",
"children":[
"Weeks 6-12"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"53f090",
"class":"cell txt l",
"children":[
"If warfarin daily dose ≤5 mg for therapeutic INR"
]
},
" ",
{
"type":"p",
"hlId":"cf920c",
"class":"cell txt li",
"children":[
"Continue warfarin (class 2a recommendation)"
]
},
" ",
{
"type":"p",
"hlId":"71c774",
"class":"cell txt li",
"children":[
"UFH: IV; aPTT 2 × control (class 2b recommendation)"
]
},
" ",
{
"type":"p",
"hlId":"785491",
"class":"cell txt li",
"children":[
"Anti–factor Xa adjusted LMWH (class 2b recommendation)"
]
},
" ",
{
"type":"p",
"hlId":"32cbb2",
"class":"cell txt l",
"children":[
"If warfarin daily dose >5 mg for therapeutic INR"
]
},
" ",
{
"type":"p",
"hlId":"eea1c5",
"class":"cell txt li",
"children":[
"UFH: IV; aPTT 2 × control (class 2a recommendation)"
]
},
" ",
{
"type":"p",
"hlId":"8c0dcd",
"class":"cell txt li",
"children":[
"Anti–factor Xa adjusted LMWH (class 2a recommendation)"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_3-2 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"5ad4d8",
"class":"cell txt l",
"children":[
"Weeks 13-37"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"46f963",
"class":"cell txt l",
"children":[
"Warfarin (therapeutic INR)"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_3-3 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"121d94",
"class":"cell txt l",
"children":[
"Weeks 37 to term"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"910e13",
"class":"cell txt l",
"children":[
"UFH (IV; aPTT 2 × control)"
]
},
" "
]
}
]
}
]
}
]
},
"footnotes":[
[
"aPTT = activated partial thromboplastin time; IV = intravenous; LMWH = low-molecular-weight heparin; SQ = subcutaneous; UFH = unfractionated heparin."
],
[
"Recommendations from Otto CM, Nishimura RA, Bonow RO, et al. 2020 ACC/AHA guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2021;143:e72-e227. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/33332150",
"target":"_blank"
},
"children":[
"PMID: 33332150"
]
},
" doi:10.1161/CIR.0000000000000923 ",
{
"type":"tag",
"tagName":"i",
"attrs":{
},
"children":[
"and"
]
},
" Bates SM, Rajasekhar A, Middeldorp S, et al. American Society of Hematology 2018 guidelines for management of venous thromboembolism: venous thromboembolism in the context of pregnancy. Blood Adv. 2018;2:3317-3359. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/30482767",
"target":"_blank"
},
"children":[
"PMID: 30482767"
]
},
" doi:10.1182/bloodadvances.2018024802 ",
{
"type":"tag",
"tagName":"i",
"attrs":{
},
"children":[
"and"
]
},
" Lip GYH, Banerjee A, Boriani G, et al. Antithrombotic therapy for atrial fibrillation: CHEST guideline and expert panel report. Chest. 2018;154:1121-1201. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/30144419",
"target":"_blank"
},
"children":[
"PMID: 30144419"
]
},
" doi:10.1016/j.chest.2018.07.040"
]
]
}